Although further studies are needed to determine the clinical relevance of the AAV1–Rheb(S16H) transduction approach for neurodegenerative diseases, this approach may be a useful strategy for protecting hippocampal neurons in the lesioned brain, and its effects may be beneficial for patients with neurodegenerative diseases such as AD. Here, RHEB is linked to Alzheimer disease.